Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensions

Journal of Hematotherapy and Stem Cell Research

Volumn 9, Issue 2, 2000, Pages 275-284

  Trummer, Arne ^a   Kadar, Janos ^a,b   Arseniev, Lubomir ^a   Petersen, Detlev ^a,c   Ganser, Arnold ^a   Lichtinghagen, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b DRK BSD NRW   (Germany)

^c KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN 19; MESSENGER RNA;

ARTICLE; BLOOD CELL; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; METASTASIS; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES; BINDING, COMPETITIVE; BLOOD SPECIMEN COLLECTION; BREAST NEOPLASMS; DIGOXIGENIN; DNA PRIMERS; DNA PROBES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KERATINS; LEUKOCYTES, MONONUCLEAR; PSEUDOGENES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY;

EID: 0034124654     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581600319504     Document Type: Article

References (52)

1. Mansi JL, H Gogas, JM Bliss, JC Gazet, U Berger and RC Coombes. (1999). Outcome of primary breast cancer patients with micrometastases: a long-term follow-up study. Lancet 354:197-202.
2. Landys K, S Persson, J Kovarik, R Hultborn and E Holmberg. (1998). Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: results of a 20-year median follow-up. Breast Cancer Res Treat 49:27-33.
3. Vredenburgh JJ, O Silva, G Broadwater, D Berry, K DeSombre, C Tyer, WP Petros, WP Peters and RCJ Bast. (1997). The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support. Biol Blood Marrow Transplant 3:91-97.
4. Diel IJ, M Kaufmann, SD Costa, R Holle, G von Minckwitz, EF Solomayer, S Kaul and G Bastert. (1996). Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 88:1652-1658.
5. Harbeck N, M Untch, L Pache and W Eiermann. (1994). Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69:566-571.
6. Cooper BW, TJ Moss, AA Ross, J Ybanez and HM Lazarus. (1998). Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer. J Clin Oncol 16:3509-3517.
7. Vannucchi AM, A Bosi, S Glinz, P Pacini, S Linari, R Saccardi, R Alterini, L Rigacci, S Guidi, L Lombardini, G Longo, MP Mariani and P Rossi-Ferrini. (1998). Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collection by RT-PCR for cytokeratin-19 mRNA. Br J Haematol 103:610-617.
8. Brockstein BE, AA Ross, TJ Moss, DG Kahn, K Hollingsworth and SF Williams. (1996). Tumor cell contamination of bone marrow harvest products: clinical consequences in a cohort of advanced-stage breast cancer patients undergoing high-dose chemotherapy. J Hematother 5:617-624.
9. Pedrazzoli P, M Battaglia, PG Da, A Lanza, A Cuomo, F Bertolini, L Pavesi and dC Robustelli. (1999). Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy. Bone Marrow Transplant 20:167-169.
10. Schulze R, M Schulze, A Wischnik, S Ehnle, K Doukas, W Behr, W Ehret and G Schlimok. (1997). Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant 19:1223-1228.
11. Battaglia M, P Pedrazzoli, B Palermo, A Lanza, F Bertolini, N Gibelli, PG Da, A Zambelli, C Perotti and dC Robustelli. (1998). Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: a new sensitive one step method without false positive results. Bone Marrow Transplant 22:693-698.
12. Eaton MC, JE Hardingham, D Kotasek and A Dobrovic. (1997). Immunobead RT-PCR: a sensitive method for detection of circulating tumor cells. Biotechniques 22:100-105.
13. Hildebrandt M, MY Mapara, IJ Körner, R Bargou, G Moldenhauer and B Dörken. (1997). RT-PCR-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency. Exp Hematol 25:57-65.
14. Kruger WH, M Stockschlader, S Hennings, M Aschenbrenner, M Gruber, K Gutensohn, C Loliger, F Gieseking, W Jonat and AR Zander. (1996). Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant 18(Suppl 1):S18-S20.
15. Luke S, and K Kaul. (1998). Detection of breast cancer cells in blood using immunomagnetic bead selection and reverse transcription-polymerase chain reaction. Mol Diagn 3:149-155.
16. Noguchi S, T Aihara, K Motomura, H Inaji, S Imaoka and H Koyama. (1996). Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 148:649-656.
17. Schoenfeld A, KH Kruger, J Gomm, HD Sinnett, JC Gazet, N Sacks, HG Bender, Y Lugmani and RC Coombes. (1997). The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33:854-861.
18. Traweek ST, J Liu and H Battifora. (1993). Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 142:1111-1118.
19. Pantel K, and A Ahr. (1998). Immunocytochemical and molecular strategies for the detection of micrometastases in patients with solid epithelial tumours: a review. Nucl Med Commun 19:521-527.
20. Burchill SA, MF Bradbury, K Pittman, J Southgate, B Smith and P Selby. (1995). Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71:278-281.
21. Datta YH, PT Adams, WR Drobyski, SP Ethier, VH Terry and MS Roth. (1994). Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482.
22. Dingemans AM, RH Brakenhoff, PE Postmus and G Giaccone. (1997). Detection of cytokeratin-19 transcripts by reverse-transcriptase polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest 77:213-220.
23. Eltahir EM, DS Mallinson, CD Birnie, C Hagan, WE George and AD Purushotham. (1998). Putative markers for the detection of breast carcinoma cells in blood. Br J Cancer 77:1203-1207.
24. Fields KK, GJ Elfenbein, WL Trudeau, JB Perkins, WE Janssen and LC Moscinski. (1996). Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14:1868-1876.
25. Krismann M, B Todt, J Schroder, D Gareis, KM Muller, S Seeber and J Schutte. (1995). Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13:2769-2775.
26. Lopez-Guerrero JA, P Bolufer-Gilabert, M Sanz-Alonso, E Barragan-Gonzalez, J Palau-Perez J, de la Rubia-Comos, A Sempere-Talens and S Bonanad-Boix. (1997). Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcrip-tion PCR method (RT-PCR). Clin Chim Acta 263:105-116.
27. Moscinski LC, WL Trudeau, KK Fields and GJ Elfenbein. (1996). High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 5:173-180.
28. Schoenfeld A, Y Luqmani, D Smith, S O'Reilly, S Shousha, HD Sinnett and RC Coombes. (1994). Detection of breast cancer micrometastases in axillary lumph nodes by using polymerase chain reaction. Cancer Res 54:2986-2990.
29. Traystman MD, GT Cochran, SJ Hake, CA Kuszynski, SL Mann, BJ Murphy, SJ Pirruccello, E Zuvanich and JG Sharp. (1997). Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells in hematopoietic harvests. J Hematother 6:551-561.
30. Zhong XY, S Kaul, I Diel, A Eichler and G Bastert. (1999). Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products. J Cancer Res Clin Oncol 125:286-291.
31. Ruud P, O Fodstad and E Hovig. (1999). Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 80:119-125.
32. Pantel K, RJ Cote and O Fodstad. (1999). Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91:1113-1124.
33. Tsai SJ, and MC Wiltbank. (1996). Quantification of mRNA using competitive RT-PCR with standard-curve methodology. Biotechniques 21:862-866.
34. Savtchenko ES, TA Schiff, CK Jiang, IM Freedberg and M Blumenberg. (1988). Embryonic expression of the human 40-kD keratin: evidence from a processed pseudogene sequence. Am J Hum Genet 43:630-637.
35. Tatusova TA, and TL Madden. (1999). BLAST 2 sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 174:247-250.
36. Burchill SA, IJ Lewis and P Selby. (1999). Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells. Br J Cancer 79:971-977.
37. Lichtinghagen R, R Diedrich-Glaubitz and B von Horsten. (1994). Identification of Bordetella pertussis in nasopharyngeal swabs using the polymerase chain reaction: evaluation of detection methods. Eur J Clin Chem Clin Biochem 32:161-167.
38. Hall LL, GR Bicknell, L Primrose, JH Pringle, JA Shaw and PN Furness. (1998). Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA. Biotechniques 24:652-658.
39. Lichtinghagen R, and R Glaubitz. (1995). A competitive polymerase chain reaction assay for reliable identification of Bordetella pertussis in nasopharyngeal swabs. Eur J Clin Chem Clin Biochem 33:87-93.
40. Sambrook S, EF Fritsch and T Maniatis. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
41. Stasiak PC, and EB Lane. (1987). Sequence of cDNA coding for human keratin 19. Nucleic Acids Res 15:10058.
42. Freeman WM, SJ Walker and KE Vrana. (1999). Quantitative RT-PCR: pitfalls and potential. Biotechniques 26:112-115.
43. Büttner J. (1993). Evaluation of diagnostic and prognostic measures. In: Evaluation Methods in Laboratory Medicine. R Haeckel ed. VCH GmbH, Weinheim, New York, Basel, Cambridge, pp 1-46.
44. Brenner MK, DR Rill and RC Moen. (1993). Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341:85-87.
45. Rill DR, VM Santana and WM Roberts. (1994). Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-383.
46. Thor A, MJ Viglione, N Ohuchi, J Simpson, R Steis, J Cousar, M Lippman, DW Kufe and J Schlom. (1988). Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow. Breast Cancer Res Treat 11:133-145.
47. Borgen E, K Beiske, S Trachsel, JM Nesland, G Kvalheim, TK Herstad, E Schlichting, H Qvist and B Naume. (1998). Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution of plasma cells directly reactive to alkaline phosphatase. J Pathol 185:427-434.
48. Lopez-Guerrero JA, PB Gilabert, EB Gonzalez, AM Sanz, JP Perez, AS Talens, EA Oraval, J de la Rubia-Comos and SB Boix. (1999). Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry. J Hematother 8:53-61.
49. Taniguchi A, H Kohsaka and DA Carson. (1994). Competitive RT-PCR ELISA: a rapid, sensitive and non-radioactive method to quantitate cytokine mRNA. J Immunol Methods 169:101-109.
50. Raeymaekers L. (1993). Quantitative PCR: theoretical considerations with practical implications. Anal Biochem 214:582-585.
51. Slade MJ, BM Smith, HD Sinnett, NC Cross and RC Coombes. (1999). Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 17:870-879.
52. Braun S, F Hepp, HL Sommer and K Pantel. (1999). Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int J Cancer 84:1-5.